These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17476172)

  • 1. Breast cancer cases decline; may be tied to drop in hormone use.
    Mayo Clin Womens Healthsource; 2007 May; 11(5):3. PubMed ID: 17476172
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
    Chu DZ
    J Natl Cancer Inst; 2008 Apr; 100(8):596-7. PubMed ID: 18398103
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
    Byers T; Trujillo S; Hines L
    J Natl Cancer Inst; 2008 Apr; 100(8):596. PubMed ID: 18398102
    [No Abstract]   [Full Text] [Related]  

  • 4. Hormone therapy and the rise and perhaps fall of US breast cancer incidence rates: critical reflections.
    Krieger N
    Int J Epidemiol; 2008 Jun; 37(3):627-37. PubMed ID: 18375445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent declines in hormone therapy utilization and breast cancer incidence: clinical and population-based evidence.
    Clarke CA; Glaser SL; Uratsu CS; Selby JV; Kushi LH; Herrinton LJ
    J Clin Oncol; 2006 Nov; 24(33):e49-50. PubMed ID: 17114650
    [No Abstract]   [Full Text] [Related]  

  • 6. Press statement. Breast cancer and hormone therapy: a looking-glass mirror?
    Pines A; Sturdee D; Birkhäuser M;
    Climacteric; 2007 Oct; 10(5):356-7. PubMed ID: 17852137
    [No Abstract]   [Full Text] [Related]  

  • 7. Drop in breast cancer may reflect decline in hormone use.
    Harv Womens Health Watch; 2007 Jul; 14(11):7. PubMed ID: 17663065
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hormone replacement therapy and breast cancer].
    Mueck AO
    Med Monatsschr Pharm; 2002 Oct; 25(10):337-47. PubMed ID: 12404946
    [No Abstract]   [Full Text] [Related]  

  • 9. Breast cancer incidence and use of hormone therapy in Denmark 1978-2007.
    von Euler-Chelpin M
    Cancer Causes Control; 2011 Feb; 22(2):181-7. PubMed ID: 21103920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the decrease in hormone replacement therapy also affect breast cancer risk in the Netherlands?
    Soerjomataram I; Coebergh JW; Louwman MW; Visser O; van Leeuwen FE
    J Clin Oncol; 2007 Nov; 25(31):5038-9; author reply 5039-40. PubMed ID: 17971608
    [No Abstract]   [Full Text] [Related]  

  • 11. Postmenopausal hormone therapy and breast cancer.
    Prescrire Int; 2009 Apr; 18(100):66-7. PubMed ID: 19585723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incidence of breast cancer and changes in the use of hormone replacement therapy: a review of the evidence.
    Verkooijen HM; Bouchardy C; Vinh-Hung V; Rapiti E; Hartman M
    Maturitas; 2009 Oct; 64(2):80-5. PubMed ID: 19709827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.
    Caan B; Habel L; Quesenberry C; Kushi L; Herrinton L
    J Natl Cancer Inst; 2008 Apr; 100(8):597-8; author reply 599. PubMed ID: 18398101
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hormone replacement therapy in postmenopausal women and breast cancer risk: impact of estrogens deprivation and timing hypothesis].
    Brettes JP; Mathelin C
    Gynecol Obstet Fertil; 2007 Nov; 35(11):1092-4. PubMed ID: 17996474
    [No Abstract]   [Full Text] [Related]  

  • 15. Commentary: Hormone therapy and breast cancer incidence: did epidemiologists miss an effect on national trends?
    Paul C
    Int J Epidemiol; 2008 Jun; 37(3):638-40. PubMed ID: 18375444
    [No Abstract]   [Full Text] [Related]  

  • 16. [Alarming data on the risk of breast cancer following estrogen replacement therapy should be interpreted carefully].
    Odlind V
    Lakartidningen; 2005 Apr 18-24; 102(16):1217-8. PubMed ID: 15921094
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hormone therapy and breast cancer].
    Olsen J
    Ugeskr Laeger; 2003 Sep; 165(38):3631-2. PubMed ID: 14556398
    [No Abstract]   [Full Text] [Related]  

  • 18. Postmenopausal hormone drugs and breast and colon cancer: Nordic countries 1995-2005.
    Hemminki E; Kyyrönen P; Pukkala E
    Maturitas; 2008 Dec; 61(4):299-304. PubMed ID: 18996655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone therapy ups cancer risk and...promotes mental decline.
    Health News; 2003 Aug; 9(8):7-8. PubMed ID: 12971319
    [No Abstract]   [Full Text] [Related]  

  • 20. [Breast cancer risk with hormone replacement therapy. A matter of interpretation].
    Röhm W
    MMW Fortschr Med; 2004 Feb; 146(6):15; author reply 15. PubMed ID: 15035307
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.